Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2013, Article ID 369609, 9 pages
http://dx.doi.org/10.1155/2013/369609
Research Article

Tannic Acid Preferentially Targets Estrogen Receptor-Positive Breast Cancer

1Institute for Biological Interfaces of Engineering, Clemson University, Clemson, SC 29634, USA
2Department of Bioengineering, Clemson University, Clemson, SC 29634, USA

Received 17 July 2013; Revised 26 September 2013; Accepted 27 September 2013

Academic Editor: Claudio Luparello

Copyright © 2013 Brian W. Booth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin and L. M. G. Fernández, “Use of statistics to assess the global burden of breast cancer,” Breast Journal, vol. 12, no. 1, supplement, pp. S70–S80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Desantis, R. Siegel, P. Bandi, and A. Jemal, “Breast cancer statistics, 2011,” CA Cancer Journal for Clinicians, vol. 61, no. 6, pp. 409–418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Manson, “Cancer prevention—the potential for diet to modulate molecular signalling,” Trends in Molecular Medicine, vol. 9, no. 1, pp. 11–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Reddy, B. Odhav, and K. D. Bhoola, “Natural products for cancer prevention: a global perspective,” Pharmacology and Therapeutics, vol. 99, no. 1, pp. 1–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Fresco, F. Borges, C. Diniz, and M. P. M. Marques, “New insights on the anticancer properties of dietary polyphenols,” Medicinal Research Reviews, vol. 26, no. 6, pp. 747–766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Shu, K.-L. Cheung, T. O. Khor, C. Chen, and A.-N. Kong, “Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis,” Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 483–502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Tan, I. Konczak, D. M.-Y. Sze, and I. Ramzan, “Molecular pathways for cancer chemoprevention by dietary phytochemicals,” Nutrition and Cancer, vol. 63, no. 4, pp. 495–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. W.-Y. Huang, Y.-Z. Cai, and Y. Zhang, “Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention,” Nutrition and Cancer, vol. 62, no. 1, pp. 1–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-J. Weng and G.-C. Yen, “Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives,” Cancer Treatment Reviews, vol. 38, no. 1, pp. 76–87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Attoub, A. H. Hassan, B. Vanhoecke et al., “Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells,” European Journal of Pharmacology, vol. 651, no. 1–3, pp. 18–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Khan, V. M. Adhami, and H. Mukhtar, “Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies,” Nutrition and Cancer, vol. 61, no. 6, pp. 836–841, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Link, F. Balaguer, and A. Goel, “Cancer chemoprevention by dietary polyphenols: promising role for epigenetics,” Biochemical Pharmacology, vol. 80, no. 12, pp. 1771–1792, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Nguewa and A. Calvo, “Use of transgenic mice as models for prostate cancer chemoprevention,” Current Molecular Medicine, vol. 10, no. 8, pp. 705–718, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Sharif, C. Auger, M. Alhosin et al., “Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redox-sensitive up-regulation of p73 and down-regulation of UHRF1,” European Journal of Cancer, vol. 46, no. 5, pp. 983–994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Szliszka and W. Krol, “The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention,” European Journal of Cancer Prevention, vol. 20, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Yang, K. Landis-Piwowar, T. H. Chan, and Q. P. Dou, “Green tea polyphenols as proteasome inhibitors: implication in chemoprevention,” Current Cancer Drug Targets, vol. 11, no. 3, pp. 296–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Isenburg, D. T. Simionescu, and N. R. Vyavahare, “Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall,” Biomaterials, vol. 26, no. 11, pp. 1237–1245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. N. Losso, R. R. Bansode, A. Trappey II, H. A. Bawadi, and R. Truax, “In vitro anti-proliferative activities of ellagic acid,” Journal of Nutritional Biochemistry, vol. 15, no. 11, pp. 672–678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Boitier, J.-C. Gautier, and R. Roberts, “Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease,” Comparative Hepatology, vol. 2, article 3, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. H. A. Bawadi, R. R. Bansode, A. Trappey II, R. E. Truax, and J. N. Losso, “Inhibition of Caco-2 colon, MCF-7 and Hs578T breast, and DU 145 prostatic cancer cell proliferation by water-soluble black bean condensed tannins,” Cancer Letters, vol. 218, no. 2, pp. 153–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Glowacki and S. Mizuno, “Collagen scaffolds for tissue engineering,” Biopolymers, vol. 89, no. 5, pp. 338–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. F. H. Heijmen, J. S. Du Pont, E. Middelkoop, R. W. Kreisn, and M. J. Hoekstra, “Cross-linking of dermal sheep collagen with tannic acid,” Biomaterials, vol. 18, no. 10, pp. 749–754, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Natarajan, N. Krithica, B. Madhan, and P. K. Sehgal, “Preparation and properties of tannic acid cross-linked collagen scaffold and its application in wound healing,” Journal of Biomedical Materials Research Part B, vol. 101, pp. 560–567, 2013. View at Google Scholar
  24. C. A. P. Cass and K. J. L. Burg, “Tannic acid cross-linked collagen scaffolds and their anti-cancer potential in a tissue engineered breast implant,” Journal of Biomaterials Science, vol. 23, no. 1–4, pp. 281–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. B. Vernon, M. D. Gooden, S. L. Lara, and T. N. Wight, “Microgrooved fibrillar collagen membranes as scaffolds for cell support and alignment,” Biomaterials, vol. 26, no. 16, pp. 3131–3140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. T. A. Tebb, S.-W. Tsai, V. Glattauer, J. F. White, J. A. M. Ramshaw, and J. A. Werkmeister, “Development of porous collagen beads for chondrocyte culture,” Cytotechnology, vol. 52, no. 2, pp. 99–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Cailleau, R. Young, M. Olive, and W. J. Reeves Jr., “Breast tumor cell lines from pleural effusions,” Journal of the National Cancer Institute, vol. 53, no. 3, pp. 661–674, 1974. View at Google Scholar · View at Scopus
  28. H. D. Soule, J. Vazquez, and A. Long, “A human cell line from a pleural effusion derived from a breast carcinoma,” Journal of the National Cancer Institute, vol. 51, no. 5, pp. 1409–1416, 1973. View at Google Scholar · View at Scopus
  29. H. D. Soule, T. M. Maloney, S. R. Wolman et al., “Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10,” Cancer Research, vol. 50, no. 18, pp. 6075–6086, 1990. View at Google Scholar · View at Scopus
  30. D. T. Cosan, A. Soyocak, A. Basaran, I. Degirmenci, H. V. Gunes, and F. M. Sahin, “Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines,” Molecular Biology Reports, vol. 38, no. 4, pp. 2463–2469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. N. A. Thornberry, T. A. Rano, E. P. Peterson et al., “A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis,” Journal of Biological Chemistry, vol. 272, no. 29, pp. 17907–17911, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. H. R. Stennicke, M. Renatus, M. Meldal, and G. S. Salvesen, “Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8,” Biochemical Journal, vol. 350, no. 2, pp. 563–568, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Liang, C. Yan, and N. F. Schor, “Apoptosis in the absence of caspase 3,” Oncogene, vol. 20, no. 45, pp. 6570–6578, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Boucher, V. Blais, and J.-B. Denault, “Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 15, pp. 5669–5674, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Brewster, G. N. Hortobagyi, K. R. Broglio et al., “Residual risk of breast cancer recurrence 5 years after adjuvant therapy,” Journal of the National Cancer Institute, vol. 100, no. 16, pp. 1179–1183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. L. Maughan, M. A. Lutterbie, and P. S. Ham, “Treatment of breast cancer,” American Family Physician, vol. 81, no. 11, pp. 1339–1346, 2010. View at Google Scholar · View at Scopus
  37. S. E. Logue and S. J. Martin, “Caspase activation cascades in apoptosis,” Biochemical Society Transactions, vol. 36, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. C. Taylor, S. P. Cullen, and S. J. Martin, “Apoptosis: controlled demolition at the cellular level,” Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 231–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Van Herreweghe, N. Festjens, W. Declercq, and P. Vandenabeele, “Tumor necrosis factor-mediated cell death: to break or to burst, that's the question,” Cellular and Molecular Life Sciences, vol. 67, no. 10, pp. 1567–1579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Zakeri and R. A. Lockshin, “Cell death: history and future,” Advances in Experimental Medicine and Biology, vol. 615, pp. 1–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-B. Denault, B. P. Eckelman, H. Shin, C. Pop, and G. S. Salvesen, “Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9,” Biochemical Journal, vol. 405, no. 1, pp. 11–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Srinivasula, M. Ahmad, T. Fernandes-Alnemri, and E. S. Alnemri, “Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization,” Molecular Cell, vol. 1, no. 7, pp. 949–957, 1998. View at Google Scholar · View at Scopus